John F. Neylan, See Remarks at Angion Biomedica Corp. (ANGN), sold 365 shares at $10.98 ($4K) on 2021-07-21, disclosed to the SEC on 2021-07-22.
Scheduled sale ($4k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANGN | SELL | 2021-10-20 | $3K | — | Filing → |
| ANGN | SELL | 2021-09-21 | $4K | — | Filing → |
| ANGN | SELL | 2021-08-19 | $3K | — | Filing → |